LUNG
Pulmonx Corp
1.90$
-5.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3.9% | -7.4% | +4.9% | -3.0% | -2.7% | -7.4% | -2.4% | -6.1% | -6.5% | -7.2% | -4.4% | |
| – | +2.1% | -1.7% | -1.2% | -3.6% | -3.3% | -9.0% | -3.2% | -7.3% | -8.6% | -8.8% | -5.0% | |
| – | -12.2% | -16.0% | -9.5% | -0.2% | +12.0% | +5.1% | +1.2% | +1.4% | -8.5% | -12.1% | -9.3% | |
| – | +0.3% | -0.8% | -1.4% | -5.9% | -5.8% | -12.6% | -5.0% | -9.1% | -8.5% | -12.1% | -9.3% | |
| – | +16.0% | -14.1% | +5.4% | +4.6% | +11.9% | +5.9% | +12.3% | -12.8% | -15.6% | -6.6% | +8.7% | |
| – | +3.8% | +2.9% | -1.4% | -0.1% | -0.3% | -0.6% | -3.8% | +0.5% | -2.5% | +2.9% | +0.5% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -50.0% | – | – | – | – | – | – | – | – | +0.0% | – | |
| – | +0.3% | -9.0% | +32.1% | +2.8% | +4.9% | -5.2% | +6.9% | +0.2% | -3.9% | -1.3% | +1.8% | |
| – | +13.0% | -8.0% | -23.4% | +12.3% | +33.5% | +2.1% | -10.0% | +1.9% | -12.3% | -5.7% | +7.9% | |
| – | +48.3% | +51.5% | -85.3% | +22.4% | +177.5% | +125.2% | -86.3% | +1.8% | +6.0% | +2.1% | +2.8% | |
| – | -53.1% | +108.8% | +1.8% | +43.9% | -16.4% | +11.8% | +53.2% | -2.1% | -39.2% | -11.0% | +34.6% | |
| – | -5.6% | -8.8% | +16.0% | +0.1% | -8.4% | -13.6% | +25.9% | +0.0% | -0.1% | +0.6% | +0.6% | |
| – | -5.9% | -6.6% | -8.4% | -7.2% | -8.6% | -9.5% | -11.0% | -13.1% | -9.9% | -15.4% | -14.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.7% | +0.7% | +0.8% | +0.9% | -0.4% | +2.2% | +0.6% | +1.8% | +1.1% | +1.2% | +0.7% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.